Hypertension and insulin resistance in a mixed-breed population of ponies predisposed to laminitis

American Journal of Veterinary Research

Volumn 69, Issue 1, 2008, Pages 122-129

  Bailey, Simon R ^a,b   Habershon Butcher, Jocelyn L ^a   Ransom, Kathryn J ^a   Elliott, Jonathan ^a   Menzies Gow, Nicola J ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GLUCOSE; INSULIN; TRIACYLGLYCEROL; URIC ACID;

ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY CONSTITUTION; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DISEASE PREDISPOSITION; FEMALE; GLUCOSE BLOOD LEVEL; HORSE; HORSE DISEASE; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PASTURE; PHENOTYPE; RECURRENT DISEASE; SCORING SYSTEM; SUMMER; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WINTER;

ADRENOCORTICOTROPIC HORMONE; ANIMAL HUSBANDRY; ANIMALS; BODY COMPOSITION; FEMALE; FOOT DISEASES; GENETIC PREDISPOSITION TO DISEASE; HORSE DISEASES; HORSES; HYPERTENSION; INSULIN RESISTANCE; MALE; SEASONS;

ANIMALIA;

EID: 38749117538     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.69.1.122     Document Type: Article

References (40)

1. Harris PA, Bailey SR, Elliott J, et al. Countermeasures for pasture-associated laminitis in ponies and horses. J Nutr 2006;136:2114S-2121S.
2. Coffman JR, Colles CM. Insulin tolerance in laminitic ponies. Can J Comp Med 1983;47:347-351.
3. Field JR, Jeffcott LB. Equine laminitis - another hypothesis for pathogenesis. Med Hypotheses 1989;30:203-210.
4. Johnson PJ. The equine metabolic syndrome peripheral Cushing's syndrome. Vet Clin North Am Equine Pract 2002;18:271-293.
5. Reaven G. Metabolic syndrome: pathophysiotogy and implications for management of cardiovascular disease. Circulation 2002; 106:286-288.
6. Treiber KH, kronfeld DS, Hess TM, et al. Evaluation of genetic and metabolic predispositions and nutritional risk factors for pasture-associated laminitis in ponies. J Am Vet Med Assoc 2006;228:1538-1545.
7. Treiber KH, Hess TM, Kronfeld DS, et al. Insulin resistance and compensation in laminitis-predisposed ponies characterized by the minimal model, in Proceedings. Equine Nutr Symp 2005;21:91-92.
8. Longland AC, Byrd BM. Pasture nonstructural carbohydrates and equine laminitis. J Nutr 2006;136:2099S-2102S.
9. Treiber KH, Boston RC, Kronfeld DS, et al. Insulin resistance and compensation in Thoroughbred weanlings adapted to high-glycaemic meals. J Anim Sci 2005;83:2357-2364.
10. Donaldson MT, Jorgensen AJ, Beech J. Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis. J Am Vet Med Assoc 2004;224:1123-1127.
11. Henneke DR, Potter GD, Kreider JL, et al. Relationship between condition score, physical measurements and body fat percentage in mares. Equine Vet J 1983;15:371-372.
12. Carroll CL, Huntingdon PJ. Body condition scoring and weight estimation of horses. Equine Vet J 1988;20:41-45.
13. Muir WW, Wade A, Grospitch B. Automatic noninvasive sphygmomanometry in horses. J Am Vet Med Assoc 1983;182:1230-1233.
14. Menzies-Gow NJ, Bailey SR, Katz LM, et al. Endotoxin-induced digital vasoconstriction in horses: associated changes in plasma concentrations of vasoconstrictor mediators. Equine Vet J 2004;36:273-278.
15. Treiber KH, Kronfeld DS, Hess TM, et al. Use of proxies and reference quintiles obtained from minimal model analysis for determination of insulin sensitivity and pancreatic beta-cell responsiveness in horses. Am J Vet Res 2005;66:2114-2121.
16. Treiber KH, Kronfeld DS, Geor RJ. Insulin resistance in equids: possible role in laminitis. J Nutr 2006;136:2094S-2098S.
17. Jeffcott LB, Field JR, McLean JG, et al. Glucose tolerance and insulin sensitivity in ponies and Standardbred horses. Equine Vet J 1986;18:97-101.
18. Hoffman RM, Boston RC, Stefanovski D, et al. Obesity and diet affect glucose dynamics and insulin sensitivity in Thoroughbred geldings. J Anim Sci 2003;81:2333-2342.
19. Frank N, Elliott SB, Brandt LE, et al. Physical characteristics, blood hormone concentrations and plasma lipid concentrations in obese horses with insulin resistance. J Am Vet Med Assoc 2006;228:1383-1390.
20. Johnson PJ, Messer NT, Slight SH, et al. Endocrinopathic laminitis in the horse. Clin Tech Equine Pract 2004;3:45-56.
21. Love S. Equine Cushing's disease. Br Vet J 1993;149:139-53.
22. McCue PM. Equine Cushing's disease. Vet Clin North Am Equine Pract 2002;18:533-543.
23. Donaldson MT, McDonnell SM, Schanbacher BJ, et al. Variation in plasma adrenocorticotropic hormone concentration and dexamethasone suppression test results with season, age and sex in healthy ponies and horses. J Vet Intern Med 2005;19:217-222.
24. Reaven GM. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. Panminerva Med 2005;47:201-210.
25. Wassink AM, Olijhoek JK, Visseren FL. The metabolic syndrome: metabolic changes with vascular consequences. Eur J Clin Invest 2007; 37:8-17.
26. Galley HF, Webster NR. Physiology of the endothelium. Br J Anaesth 2004;93:105-113.
27. Hood DM, Gsosenbaugh DA, Mostafa MB, et al. The role of vascular mechanisms in the development of acute equine laminitis. J Vet Intern Med 1993;7:228-234.
28. Black SJ, Lunn DP, Yin C, et al. Leukocyte emigration in the early stages of laminitis. Vet Immunol Immunopathol 2006;109:161-166.
29. Pass MA, Pollitt S, Pollitt CC. Decreased glucose metabolism causes separation of hoof lamellae in vitro: a trigger for laminitis? Equine Vet J Suppl 1998;26:133-138.
30. French KR, Pollitt CC. Equine laminitis: glucose deprivation and MMP activation induce dermo - epidermal separation in vitro. Equine Vet J 2004;36:261-266.
31. Wattle O, Pollitt CC. Lamellar metabolism. Clin Tech Equine Pract 2004;3:22-33.
32. Mobasheri A, Critchlow K, Clegg PD, et al. Chronic equine laminitis is characterised by loss of GLUT1, GLUT4 and ENaC positive laminar keratinocytes. Equine Vet J 2004;36:248-254.
33. McGowan CM, Frost R, Pfeiffer DU, et al. Serum insulin concentrations in horses with equine Cushing's syndrome: response to a cortisol inhibitor and prognostic value. Equine Vet J 2004;36:295-298.
34. Pratt SE, Geor RJ, McCutcheon LJ. Repeatability of two methods for assessment of insulin sensitivity and glucose dynamics in horses. J Vet Intern Med 2005;19:883-888.
35. Kronfeld D. Insulin resistance predicted by specific proxies. J Equine Vet Sci 2006;26:281-284.
36. NIH Adult Treatment Panel III. Third report of the expert panel on detection, evaluation and treatment of high blood cholesterol in adults. NIH publication No. 02-5215. Bethesda, Md: National Institutes of Health, 2002.
37. Grundy SM. Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance. Clin Cornerstone 2006;8(suppl 1):S21-S27.
38. Lewis GF, Uffelman K, Naples M, et al. Intestinal lipoprotein overproduction, a newly recognised component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed syrian golden hamster. Endocrinology 2005; 146:247-255.
39. Basciano H, Federico L, Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond) 2005;2:5.
40. Nakagawa T, Hu H, Zharikov S, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006;290:F625-F631.